tetradecanoylphorbol acetate has been researched along with Sezary Syndrome in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lange, CE; Röllinghoff, M; Solbach, W; Wagner, H | 1 |
| Broder, S; DiNapoli, AM; Pincus, SH; Schooley, WR | 1 |
| Davies, C; Godal, T; Kvaløy, S; Lindmo, T; Wisløff, F | 1 |
| Kadin, ME; Nasu, K; Sako, D; Su, IJ | 1 |
| Aubery, M; Badache, A; Kuchler-Bopp, S; Wantyghem, J; Zanetta, JP | 1 |
| Kelleher, D; Long, A; Magnuson, NS; Wingett, D | 1 |
| Bueso-Ramos, C; Duvic, M; Estrov, Z; Lee, BN; Reuben, JM; Tang, CK | 1 |
7 other study(ies) available for tetradecanoylphorbol acetate and Sezary Syndrome
| Article | Year |
|---|---|
Growth, interleukin-2 production, and responsiveness to IL-2 in T4-positive T Lymphocyte populations from malignant cutaneous T cell lymphoma (Sézary's syndrome): the effect of cyclosporin A.
Topics: Cyclosporins; Humans; Interleukin-2; Lymphocyte Activation; Phenotype; Phytohemagglutinins; Sezary Syndrome; T-Lymphocytes, Helper-Inducer; Tetradecanoylphorbol Acetate | 1984 |
Metabolic heterogeneity of eosinophils from normal and hypereosinophilic patients.
Topics: Eosinophilia; Eosinophils; Hexosephosphates; Humans; Leukemia; Lymphoma; Neoplasms; Sezary Syndrome; Superoxides; Tetradecanoylphorbol Acetate; Time Factors | 1981 |
Sézary cells with an unusual phenotype, their modulation with 12-O-tetradecanoyl phorbol-13-acetate (TPA) in vitro, and their relationship to T-cell development.
Topics: Aged; Antibodies, Monoclonal; B-Lymphocytes; Humans; Leukemia; Male; Phenotype; Phorbols; Receptors, Antigen, B-Cell; Sezary Syndrome; T-Lymphocytes; Tetradecanoylphorbol Acetate | 1983 |
Distinctive phorbol ester-induced morphological and surface antigen changes in mycosis fungoides, the Sézary syndrome, and adult T-cell leukemia.
Topics: Adult; Antigens, Surface; Cell Transformation, Neoplastic; Cells, Cultured; Humans; Kinetics; Leukemia; Mycosis Fungoides; Phenotype; Phorbols; Sezary Syndrome; T-Lymphocytes; Tetradecanoylphorbol Acetate | 1984 |
Human lymphocyte activation is associated with the early and high-level expression of the endogenous lectin CSL at the cell surface.
Topics: Agglutination Tests; Antigens, CD; B-Lymphocytes; CD24 Antigen; CD3 Complex; Cell Membrane; Electrophoresis, Polyacrylamide Gel; Humans; Immunoenzyme Techniques; Lectins; Ligands; Lymphocyte Activation; Membrane Glycoproteins; Phosphorylation; Sezary Syndrome; Skin Neoplasms; T-Lymphocytes; Tetradecanoylphorbol Acetate | 1995 |
pim-1 proto-oncogene expression in anti-CD3-mediated T cell activation is associated with protein kinase C activation and is independent of Raf-1.
Topics: Calcium; Cell Nucleus; Cytoplasm; Enzyme Activation; Enzyme Induction; Humans; Ionomycin; Isoenzymes; Leukemia-Lymphoma, Adult T-Cell; Lymphocyte Activation; Muromonab-CD3; Protein Kinase C; Protein Serine-Threonine Kinases; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-pim-1; Proto-Oncogene Proteins c-raf; Proto-Oncogenes; Receptor-CD3 Complex, Antigen, T-Cell; Receptors, Antigen, T-Cell; RNA, Messenger; Sezary Syndrome; Signal Transduction; Skin Neoplasms; T-Lymphocytes; Tetradecanoylphorbol Acetate; Transcription, Genetic; Transfection; Tumor Cells, Cultured | 1996 |
Dysregulated synthesis of intracellular type 1 and type 2 cytokines by T cells of patients with cutaneous T-cell lymphoma.
Topics: Case-Control Studies; Cytokines; Humans; In Vitro Techniques; Interferon-gamma; Interleukin-2; Interleukin-4; Lymphocyte Activation; Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides; Prognosis; Sezary Syndrome; Skin Neoplasms; T-Lymphocyte Subsets; T-Lymphocytes; Tetradecanoylphorbol Acetate | 1999 |